Key result
The HATCH score demonstrated a significantly higher predictive ability for all-cause mortality (AUROC 0.6618) compared to the HAVOC (0.5733) and CHA2DS2-VASc (0.6423) scores in patients with AF.
Why the study?
To evaluate and compare the predictive ability of HATCH, HAVOC, and CHA2DS2-VASc scores for all-cause mortality in patients with atrial fibrillation.
Does the HATCH score improve all-cause mortality prediction compared to HAVOC and CHA2DS2-VASc scores in patients with atrial fibrillation?
Observational (n=6,444)
Does the HATCH score improve all-cause mortality prediction compared to HAVOC and CHA2DS2-VASc scores in patients with atrial fibrillation?
The HATCH score demonstrates superior predictive ability for all-cause mortality in patients with atrial fibrillation compared to the HAVOC and CHA2DS2-VASc scores.
HATCH may aid mortality risk stratification in AF; hypothesis-generating, requires prospective validation before practice change.
OBJECTIVE: This study focused on the predictive ability of the 3 scores for all-cause mortality in 6444 patients with atrial fibrillation (AF). METHODS: To assess the predictive accuracy of risk of death modelled by HATCH, HAVOC and CHA2DS2-VASc scores, the area under the curve of receiver operating characteristics (AUROC) was applied. RESULTS: Over follow-up time, the cumulative incidence of death was clearly associated with the three scores (log-rank test, p<0.001). The AUROC for the HATCH (0.6618) was significantly higher than HAVOC Score (0.5733) and CHA2DS2-VAScs Score (0.6423). CONCLUSIONS: HATCH score has better ability in predicting mortality in comparison to other two scores in patients with AF.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2022) conducted an observational in atrial fibrillation (n=6,444). HATCH score vs. HAVOC and CHA2DS2-VASc scores was evaluated on all-cause mortality (AUROC 0.6618, p=<0.001). The HATCH score demonstrated a significantly higher predictive ability for all-cause mortality (AUROC 0.6618) compared to the HAVOC (0.5733) and CHA2DS2-VASc (0.6423) scores in patients with AF.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: